Wilson Mark Daniel
Dept. Of Surgery, Monash University, Melbourne, Australia.
Iran J Pathol. 2015 Spring;10(2):83-8.
Fibrosis is the pathological condition resulting in the growth of excess fibrous connective tissue in an organ or body system as a reparative or reactive process. In the field of clinical pathology, clinicians and medical scientists are endeavoring to translate experimental knowledge into effective, innovative treatments for a range of fibrotic conditions. The amelioration of whole organ function is at the forefront of research involving new treatment modalities. The augmentation of cardiac function following myocardial infarction is one area of research currently undergoing rapid growth internationally, but pulmonary and hepatic functions are both affected by fibrosis in numerous disease states, and chronic allograft fibrosis is an increasingly recognized problem in organ transplantation; novel treatments are thus undergoing development with ever increasing urgency. An attempt will be made to explore the dynamics of fibrosis in a range of disease states not classically recognized as having a common etiology.
纤维化是一种病理状态,作为一种修复或反应过程,会导致器官或身体系统中过多纤维结缔组织生长。在临床病理学领域,临床医生和医学科学家正努力将实验知识转化为针对一系列纤维化病症的有效、创新治疗方法。改善整个器官功能是涉及新治疗方式的研究的前沿课题。心肌梗死后心脏功能的增强是目前在国际上快速发展的一个研究领域,但在许多疾病状态下,肺和肝功能都会受到纤维化的影响,并且慢性同种异体移植纤维化在器官移植中是一个日益受到认可的问题;因此,新型治疗方法的研发正变得越来越紧迫。本文将尝试探讨在一系列通常不被认为具有共同病因的疾病状态下纤维化的动态变化。